Perfil
John Paul Gabriel is currently Chief Technical Operations Officer at Silence Therapeutics Plc since 2022.
Formerly, Mr. Gabriel was Senior Vice President-Technical Operations at Ocugen, Inc. from 2021 to 2022 and Vice President-Biologics & mRNA Manufacturing at Ultragenyx Pharmaceutical, Inc. Education includes an undergraduate degree from the University of Guelph.
Cargos activos de J.P. Gabriel
| Empresas | Cargo | Inicio |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Director Técnico/Científico/I+D | 01/11/2022 |
Antiguos cargos conocidos de J.P. Gabriel.
| Empresas | Cargo | Fin |
|---|---|---|
| OCUGEN, INC. | Corporate Officer/Principal | 01/09/2022 |
| ULTRAGENYX PHARMACEUTICAL INC. | Corporate Officer/Principal | - |
Formación de J.P. Gabriel.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Ultragenyx Pharmaceutical, Inc.
Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
Silence Therapeutics Plc
Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
University of Guelph
University of Guelph Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ocugen, Inc.
Ocugen, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes gene therapy products | Health Technology |
- Bolsa de valores
- Insiders
- J.P. Gabriel
















